Paclitaxel hypersensitivity reactions related to bee-sting allergy

被引：23

作者：

Grosen, E

Siitari, E

Larrison, E

Tiggelaar, C

Roecker, E

机构：

[1] Univ Wisconsin Hosp & Clin, Dept Obstet & Gynaecol, Madison, WI 53792 USA

[2] Univ Wisconsin Hosp & Clin, Dept Biostat & Informat, Madison, WI 53792 USA

来源：

LANCET | 2000年 / 355卷 / 9200期

关键词：

D O I：

10.1016/S0140-6736(99)04306-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with a history of bee-sting allergy may have a higher risk of a hypersensitivity reaction with paclitaxel treatment. We suggest careful screening of patients for allergies.

引用

页码：288 / 289

页数：2

共 4 条

[1]

ESSAYAN D, 1996, J ALLERGY CLIN IMMUN, V97, P1

[2] Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer [J].

McGuire, WP ;

Hoskins, WJ ;

Brady, MF ;

Kucera, PR ;

Partridge, EE ;

Look, KY ;

ClarkePearson, DL ;

Davidson, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) :1-6

[3] Taxol hypersensitivity: Rapid retreatment is safe and cost effective [J].

Olson, JK ;

Sood, AK ;

Sorosky, JI ;

Anderson, B ;

Buller, RE .

GYNECOLOGIC ONCOLOGY, 1998, 68 (01) :25-28

[4] HYPERSENSITIVITY REACTIONS FROM TAXOL [J].

WEISS, RB ;

DONEHOWER, RC ;

WIERNIK, PH ;

OHNUMA, T ;

GRALLA, RJ ;

TRUMP, DL ;

BAKER, JR ;

VANECHO, DA ;

VONHOFF, DD ;

LEYLANDJONES, B .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1263-1268

← 1 →